GCTK — GlucoTrack, Inc.
$0.4032-32.68%
Last close: · regular session
After-hours $0.4250 +5.41% ·
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for GCTK in the TickerWise workspace.
GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
- Exchange: NASDAQ Capital Market
- Employees: 11
- Website: https://www.glucotrack.com
Latest SEC filings for GCTK
Latest GCTK news
- Glucotrack announces 1-for-2 reverse stock split to maintain Nasdaq listing Read article
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.